Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 5 | 1 |
| List of Figures | 5 | 1 |
| CJ HealthCare Corp. Snapshot | 6 | 1 |
| CJ HealthCare Corp. Overview | 6 | 1 |
| Key Information | 6 | 1 |
| Key Facts | 6 | 1 |
| CJ HealthCare Corp. Research and Development Overview | 7 | 3 |
| Key Therapeutic Areas | 7 | 3 |
| CJ HealthCare Corp. Pipeline Review | 10 | 5 |
| Pipeline Products by Stage of Development | 10 | 1 |
| Pipeline Products Monotherapy | 11 | 1 |
| Pipeline Products Combination Treatment Modalities | 12 | 1 |
| Pipeline Products Partnered Products | 13 | 1 |
| Partnered Products/Combination Treatment Modalities | 14 | 1 |
| CJ HealthCare Corp. Pipeline Products Glance | 15 | 7 |
| CJ HealthCare Corp. Late Stage Pipeline Products | 15 | 1 |
| Pre-Registration Products/Combination Treatment Modalities | 15 | 1 |
| Phase III Products/Combination Treatment Modalities | 16 | 1 |
| CJ HealthCare Corp. Clinical Stage Pipeline Products | 17 | 1 |
| Phase II Products/Combination Treatment Modalities | 17 | 1 |
| Phase I Products/Combination Treatment Modalities | 18 | 1 |
| CJ HealthCare Corp. Early Stage Pipeline Products | 19 | 1 |
| IND/CTA Filed Products/Combination Treatment Modalities | 19 | 1 |
| Preclinical Products/Combination Treatment Modalities | 20 | 1 |
| Discovery Products/Combination Treatment Modalities | 21 | 1 |
| CJ HealthCare Corp. Drug Profiles | 22 | 18 |
| (ezetimibe + rosuvastatin calcium) | 22 | 1 |
| Product Description | 22 | 1 |
| Mechanism of Action | 22 | 1 |
| R&D Progress | 22 | 1 |
| (amlodipine besylate + candesartan cilexetil) | 23 | 1 |
| Product Description | 23 | 1 |
| Mechanism of Action | 23 | 1 |
| R&D Progress | 23 | 1 |
| (amlodipine besylate + rosuvastatin calcium + valsartan) | 24 | 1 |
| Product Description | 24 | 1 |
| Mechanism of Action | 24 | 1 |
| R&D Progress | 24 | 1 |
| (atorvastatin calcium + metformin hydrochloride) XR | 25 | 1 |
| Product Description | 25 | 1 |
| Mechanism of Action | 25 | 1 |
| R&D Progress | 25 | 1 |
| tegoprazan | 26 | 1 |
| Product Description | 26 | 1 |
| Mechanism of Action | 26 | 1 |
| R&D Progress | 26 | 1 |
| CJ-40006 | 27 | 1 |
| Product Description | 27 | 1 |
| Mechanism of Action | 27 | 1 |
| R&D Progress | 27 | 1 |
| darbepoetin alfa | 28 | 1 |
| Product Description | 28 | 1 |
| Mechanism of Action | 28 | 1 |
| R&D Progress | 28 | 1 |
| (amlodipine besylate + atorvastatin calcium + valsartan) | 29 | 1 |
| Product Description | 29 | 1 |
| Mechanism of Action | 29 | 1 |
| R&D Progress | 29 | 1 |
| somatropin biobetter | 30 | 1 |
| Product Description | 30 | 1 |
| Mechanism of Action | 30 | 1 |
| R&D Progress | 30 | 1 |
| NSI-566 | 31 | 1 |
| Product Description | 31 | 1 |
| Mechanism of Action | 31 | 1 |
| R&D Progress | 31 | 2 |
| CJ-14199 | 33 | 1 |
| Product Description | 33 | 1 |
| Mechanism of Action | 33 | 1 |
| R&D Progress | 33 | 1 |
| CJ-40010 | 34 | 1 |
| Product Description | 34 | 1 |
| Mechanism of Action | 34 | 1 |
| R&D Progress | 34 | 1 |
| CJ-40011 | 35 | 1 |
| Product Description | 35 | 1 |
| Mechanism of Action | 35 | 1 |
| R&D Progress | 35 | 1 |
| RQ-00000010 | 36 | 1 |
| Product Description | 36 | 1 |
| Mechanism of Action | 36 | 1 |
| R&D Progress | 36 | 1 |
| RQ-00000774 | 37 | 1 |
| Product Description | 37 | 1 |
| Mechanism of Action | 37 | 1 |
| R&D Progress | 37 | 1 |
| Small Molecules to Inhibit Janus Kinase for Rheumatoid Arthritis | 38 | 1 |
| Product Description | 38 | 1 |
| Mechanism of Action | 38 | 1 |
| R&D Progress | 38 | 1 |
| ranibizumab biosimilar | 39 | 1 |
| Product Description | 39 | 1 |
| Mechanism of Action | 39 | 1 |
| R&D Progress | 39 | 1 |
| CJ HealthCare Corp. Pipeline Analysis | 40 | 6 |
| CJ HealthCare Corp. Pipeline Products by Target | 40 | 2 |
| CJ HealthCare Corp. Pipeline Products by Route of Administration | 42 | 1 |
| CJ HealthCare Corp. Pipeline Products by Molecule Type | 43 | 1 |
| CJ HealthCare Corp. Pipeline Products by Mechanism of Action | 44 | 2 |
| CJ HealthCare Corp. Recent Pipeline Updates | 46 | 9 |
| CJ HealthCare Corp. Dormant Projects | 55 | 1 |
| CJ HealthCare Corp. Locations And Subsidiaries | 56 | 1 |
| Head Office | 56 | 1 |
| Other Locations &Subsidiaries | 56 | 1 |
| Appendix | 57 | 2 |
| Methodology | 57 | 1 |
| Coverage | 57 | 1 |
| Secondary Research | 57 | 1 |
| Primary Research | 57 | 1 |
| Expert Panel Validation | 57 | 1 |
| Contact Us | 57 | 1 |
| Disclaimer | 58 | 1 |